|
Name |
(1S,2S)-2-[(2R,4Z,6E,8S,9R,13R,15R,16R)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-yl]cyclopentane-1-carboxylic acid
|
Molecular Formula | C28H43NO6 | |
IUPAC Name* |
(1S,2S)-2-[(2R,4Z,6E,8S,9R,13R,15R,16R)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-yl]cyclopentane-1-carboxylic acid
|
|
SMILES |
C[C@H]1C[C@H]([C@@H](CC(=O)O[C@H](C/C=C\C=C(\[C@H]([C@@H](CC(C1)C)C)O)/C#N)[C@H]2CCC[C@@H]2C(=O)O)O)C
|
|
InChI |
InChI=1S/C28H43NO6/c1-17-12-18(2)14-20(4)27(32)21(16-29)8-5-6-11-25(22-9-7-10-23(22)28(33)34)35-26(31)15-24(30)19(3)13-17/h5-6,8,17-20,22-25,27,30,32H,7,9-15H2,1-4H3,(H,33,34)/b6-5-,21-8+/t17-,18?,19-,20-,22+,23+,24-,25-,27+/m1/s1
|
|
InChIKey |
OJCKRNPLOZHAOU-MJQQLCDASA-N
|
|
Synonyms |
Borrelidin; 7184-60-3
|
|
CAS | 7184-60-3 | |
PubChem CID | 133655849 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 489.6 | ALogp: | 5.6 |
HBD: | 3 | HBA: | 7 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 128.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 35 | QED Weighted: | 0.461 |
Caco-2 Permeability: | -5.346 | MDCK Permeability: | 0.00001420 |
Pgp-inhibitor: | 0.023 | Pgp-substrate: | 0.384 |
Human Intestinal Absorption (HIA): | 0.206 | 20% Bioavailability (F20%): | 0.01 |
30% Bioavailability (F30%): | 0.94 |
Blood-Brain-Barrier Penetration (BBB): | 0.029 | Plasma Protein Binding (PPB): | 98.76% |
Volume Distribution (VD): | 0.714 | Fu: | 2.59% |
CYP1A2-inhibitor: | 0.035 | CYP1A2-substrate: | 0.078 |
CYP2C19-inhibitor: | 0.045 | CYP2C19-substrate: | 0.64 |
CYP2C9-inhibitor: | 0.523 | CYP2C9-substrate: | 0.706 |
CYP2D6-inhibitor: | 0.002 | CYP2D6-substrate: | 0.038 |
CYP3A4-inhibitor: | 0.441 | CYP3A4-substrate: | 0.202 |
Clearance (CL): | 9.015 | Half-life (T1/2): | 0.876 |
hERG Blockers: | 0.027 | Human Hepatotoxicity (H-HT): | 0.969 |
Drug-inuced Liver Injury (DILI): | 0.97 | AMES Toxicity: | 0.006 |
Rat Oral Acute Toxicity: | 0.266 | Maximum Recommended Daily Dose: | 0.943 |
Skin Sensitization: | 0.634 | Carcinogencity: | 0.202 |
Eye Corrosion: | 0.005 | Eye Irritation: | 0.049 |
Respiratory Toxicity: | 0.768 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002735 | 0.283 | D08XAC | 0.253 | ||||
ENC001935 | 0.262 | D06WTZ | 0.250 | ||||
ENC005766 | 0.252 | D02DWM | 0.248 | ||||
ENC002580 | 0.250 | D0H0ND | 0.246 | ||||
ENC001414 | 0.250 | D04SFH | 0.244 | ||||
ENC003767 | 0.248 | D0F5OR | 0.244 | ||||
ENC002054 | 0.248 | D02FEM | 0.243 | ||||
ENC003784 | 0.248 | D0L6QI | 0.235 | ||||
ENC005098 | 0.248 | D0OR2L | 0.234 | ||||
ENC002215 | 0.248 | D06OMK | 0.232 |